Obesity trials in China

In China 249 Also abroad 1939

249 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Human Genes and Microbiota in Early Life
Where
Guangzhou
People
20,000
Run by
Guangzhou Women and Children's Medical Center
See details and how to joinNCT06926166
Phase 1/2Taking people
A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity
Where
Beijing
Age
18 years to 65 years
People
126
Run by
Hangzhou Sciwind Biosciences Co., Ltd.
See details and how to joinNCT07243171
No phaseTaking people
Study on the Safety and Efficacy of Domestic Single-Port Robot-Assisted Metabolic Bariatric Surgery.
Where
Beijing
Age
18 years to 65 years
People
50
Run by
China-Japan Friendship Hospital
See details and how to joinNCT07335731
Phase 1Taking people
A Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and Patients With Renal Impairment
Where
Chengdu
Age
18 years to 65 years
People
32
Run by
Fujian Shengdi Pharmaceutical Co., Ltd.
See details and how to joinNCT07807059
Phase 3Taking people
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Where
Beijing, Huzhou, Nanjing, Suzhou, Zhenjiang
Age
18 years and over
People
300 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07571005 · EU 2024-520442-36-00
Phase 1Taking people
IBI3042 Study in Healthy Participants and Overweight or Obese Participants
Where
Beijing
Age
18 years to 55 years
People
104
Run by
Innovent Biologics (Suzhou) Co. Ltd.
See details and how to joinNCT07793019
Phase 2/3Taking people
GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients
Where
Shanghai
Age
18 years to 45 years
People
80
Run by
Xiaojun Chen
See details and how to joinNCT05316935
Phase 2/3Taking people
GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients
Where
Shanghai
Age
18 years to 45 years
People
29
Run by
Xiaojun Chen
See details and how to joinNCT06379113
No phaseNot yet taking people in China
Dual GIP/GLP-1 Receptor Agonist in Obese Women Before Frozen Embryo Transfer
Where
Shanghai
Age
20 years to 40 years
People
1,510
Run by
RenJi Hospital
See details and how to joinNCT07811895
Phase 2Not yet taking people in China
A Study Evaluating Safety and Tolerability of Switching From Semaglutide to Zovaglutide in Adults With Obesity (HORIZON-SWITCH-SZ)
Where
Beijing, Changchun, Changde, Chengdu, Handan, Harbin, Huizhou, Jinan, Jincheng, Langfang, Nanyang, Shenyang, Yichang, Zibo
Age
18 years to 75 years
People
210
Run by
Beijing QL Biopharmaceutical Co.,Ltd
See details and how to joinNCT07812597
Phase 1Not yet taking people in China
Safety and Pharmacokinetics of HRS-1597 Tablets in Healthy and Obese Participants: A Phase 1 Study
Where
Hefei
Age
18 years to 55 years
People
78
Run by
Shandong Suncadia Medicine Co., Ltd.
See details and how to joinNCT07808918
Phase 1Taking people
Phase 1 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity
Where
Kunming
Age
18 years to 50 years
People
36
Run by
Shanghai Minwei Biotechnology Co., Ltd
See details and how to joinNCT07803809
Phase 2Not yet taking people in China
Efficacy and Safety of SYH2069 Injection in Obese Participants Without Diabetes.
Where
Nanjing
Age
18 years to 65 years
People
360
Run by
CSPC Ouyi Pharmaceutical Co., Ltd.
See details and how to joinNCT07803991
Phase 1Not yet taking people in China
An Exploratory Study of Single-Dose and Multiple-Doses IBI3042 in Healthy, Overweight, or Obese Participants
Where
Luoyang
Age
18 years to 55 years
People
94
Run by
Hongwei Jiang
See details and how to joinNCT07802899
No phaseEnrolling by invitation
Impact of Chronotype-Based Time-Restricted Eating on Visceral Fat and Metabolic Health in Physically Inactive Adults With Central Obesity
Where
Hong Kong
Age
18 years to 65 years
People
90
Run by
Chinese University of Hong Kong
See details and how to joinNCT07062315
Phase 3Taking people
A Study of Econoglutide Injection in Obese Participants With Knee Osteoarthritis (KOA)
Where
Wuhan
Age
18 years to 75 years
People
360
Run by
Hangzhou Sciwind Biosciences Co., Ltd.
See details and how to joinNCT07734311
Phase 1Not yet taking people in China
A Clinical Trial of TQF6422 Injection in Overweight or Obese Healthy Subjects.
Where
Shanghai
Age
18 years to 55 years
People
108
Run by
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
See details and how to joinNCT07794111
Phase 3Not yet taking people in China
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of HDM1005 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Receiving Positive Airway Pressure (PAP) Therapy
Where
Beijing
Age
18 years to 75 years
People
200
Run by
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
See details and how to joinNCT07794397
Phase 3Taking people
A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy
Where
Beijing
Age
18 years to 75 years
People
140
Run by
Hangzhou Sciwind Biosciences Co., Ltd.
See details and how to joinNCT07387094
Phase 3Taking people
A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure Therapy
Where
Shanghai
Age
18 years to 75 years
People
140
Run by
Hangzhou Sciwind Biosciences Co., Ltd.
See details and how to joinNCT07434050
Phase 1Taking people
A Clinical Trial Evaluating TQF3250 Capsules in Patients With Type 2 Diabetes Mellitus and Overweight/Obesity
Where
Changsha, Fuzhou, Guangzhou, Hangzhou, Jinan, Langfang, Luoyang, Luzhou, Nanjing, Shanghai, Wuhan, Yichang
Age
18 years to 70 years
People
72
Run by
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07747857
Phase 3Not yet taking people in China
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of HDM1005 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Not Receiving Positive Airway Pressure (PAP) Therapy
Where
Beijing
Age
18 years to 75 years
People
200
Run by
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
See details and how to joinNCT07787260
Phase 1Taking people
Phase I Drug-Drug Interaction Study of UBT251 Injection in Participants With Overweight or Obesity
Where
Hefei
Age
18 years to 45 years
People
48
Run by
The United Bio-Technology (Hengqin) Co., Ltd.
See details and how to joinNCT07785934
Phase 1Not yet taking people in China
Phase 1 Clinical Study of MWN110 Injection in Healthy Participants and Overweight or Obese Participants
Where
Kunming
Age
18 years to 65 years
People
103
Run by
Shanghai Minwei Biotechnology Co., Ltd
See details and how to joinNCT07779980
Phase 2Not yet taking people in China
Mazdutide Plus LNG-IUS for Fertility-Sparing Treatment of AEH or Early Endometrial Cancer
Where
Changchun, Hangzhou, Shanghai, Tianjin, Wuhan, Zhengzhou
Age
18 years to 45 years
People
128
Run by
Tongji Hospital
See details and how to joinNCT07781150